Page last updated: 2024-10-23

benphothiamine and Protein Aggregation, Pathological

benphothiamine has been researched along with Protein Aggregation, Pathological in 1 studies

benfotiamine : A thioester that is a synthetic analogue of thiamine obtained by acylative cleavage of the thiazole ring and O-phospohorylation.

Protein Aggregation, Pathological: A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tapias, V1
Jainuddin, S1
Ahuja, M1
Stack, C1
Elipenahli, C1
Vignisse, J1
Gerges, M1
Starkova, N1
Xu, H1
Starkov, AA1
Bettendorff, L1
Hushpulian, DM1
Smirnova, NA1
Gazaryan, IG1
Kaidery, NA1
Wakade, S1
Calingasan, NY1
Thomas, B1
Gibson, GE1
Dumont, M1
Beal, MF1

Other Studies

1 other study available for benphothiamine and Protein Aggregation, Pathological

ArticleYear
Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy.
    Human molecular genetics, 2018, 08-15, Volume: 27, Issue:16

    Topics: Amyloid beta-Peptides; Animals; Antioxidant Response Elements; Brain; Disease Models, Animal; Humans

2018